In order to confirm expression in the tumor cells, we tested TPM2 protein by IHC in 47 BL patients (10 of which were analyzed also by sc-RNAseq and/or qRT-PCR) using diagnostic tissue samples collected at multiple Institutions in Europe, USA, and Canada. This evidence concerns the gene TPM2 and Burkitt lymphoma.